Pattern of planned systemic therapy usage in newly diagnosed, nonmetastatic squamous cell carcinoma of the head and neck in a commercially insured population in the United States-Reference-Cited by-同舟云学术

Pattern of planned systemic therapy usage in newly diagnosed, nonmetastatic squamous cell carcinoma of the head and neck in a commercially insured population in the United States

Published:2018-11-13 Issue:12 Volume:40 Page:2612-2620
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head Neck

Author:

Park Jong Chul¹,Gourin Christine G.²,Kiess Ana P.³,Mehra Ranee⁴,Forastiere Arlene A.⁴⁵,Kang Hyunseok⁴^ORCID

Affiliation:

1. Department of MedicineHarvard Medical School/Massachusetts General Hospital Boston Massachusetts

2. Department of Otolaryngology ‐ Head and Neck SurgeryThe Johns Hopkins University School of Medicine Baltimore Maryland

3. Department of Radiation Oncology and Molecular Radiation SciencesThe Johns Hopkins University School of Medicine Baltimore Maryland

4. Department of OncologyThe Johns Hopkins University School of Medicine Baltimore Maryland

5. NantHealth Philadelphia Pennsylvania

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.25333

Reference50 articles.

1. Patterns of care in older patients with squamous cell carcinoma of the head and neck: A Surveillance, Epidemiology, and End Results-Medicare analysis

2. The Effect of Treating Institution on Outcomes in Head and Neck Cancer

3. Improved survival is associated with treatment at high-volume teaching facilities for patients with advanced stage laryngeal cancer

4. The impact of treatment center on the outcome of patients with laryngeal cancer treated with surgery and radiotherapy

5. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient reported outcomes in patients with head and neck cancer treated with concurrent chemoradiation with weekly versus bolus cisplatin;Head & Neck;2020-08-19